Filing Details

Accession Number:
0001535264-15-000091
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-08 16:14:58
Reporting Period:
2015-10-06
Filing Date:
2015-10-08
Accepted Time:
2015-10-08 16:14:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1279704 Cellectar Biosciences Inc. CLRB Pharmaceutical Preparations (2834) 043321804
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1535264 Awm Investment Company, Inc. 527 Madison Avenue
Suite 2600
New York NY 10022
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-10-06 2,554 $2.00 1,079,573 No 4 S Indirect By Limited Partnerships
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Limited Partnerships
Footnotes
  1. This is a weighted average price.
  2. AWM Investment Company, Inc., a Delaware corporation (AWM), is the investment adviser to Special Situations Fund III QP, L.P. (SSFQP), Special Situations Cayman Fund, L.P. (CAYMAN) and Special Situations Life Sciences Fund, L.P. (SSLS and together with SSFQP and CAYMAN, the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 509,767 shares of Common Stock of the Issuer (the Shares) held by SSFQP, 169,921 Shares held by CAYMAN and 399,885 Shares held by SSLS.
  3. Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM.The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall notbe deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of theSecurities Exchange Act of 1934, as amended, or for any other purpose.